COMMUNIQUÉS West-GlobeNewswire

Notice of Annual General Meeting in Oasmia Pharmaceutical AB

24/08/2018 - 14:00

THE SHAREHOLDERS OF OASMIA PHARMACEUTICAL AB ARE HEREBY GIVEN NOTICE OF THE ANNUAL GENERAL MEETING ON TUESDAY 25 SEPTEMBER 2018, AT 14:00 CET, AT THE OFFICES OF THE COMPANY, VALLONGATAN 1, 752 28 UPPSALA. THE [...]

American Cannabis Company, Inc. Comments on New Chief Financial Officer, Engagement of New Independent Auditor and SEC Filing Status

24/08/2018 - 14:00

DENVER, CO, Aug. 24, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC”), a full-service business-to-business consulting solutions provider, and seller of ancillary [...]

Emerald Health Therapeutics Engages Acorn Management Partners for Investor Relations

24/08/2018 - 14:00

VICTORIA, British Columbia, Aug. 24, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) today announced that it has engaged Acorn Management Partners, an Atlanta-based [...]

New Publication from AroCell AB Demonstrating the Value of Thymidine Kinase 1 as a Tumor Biomarker

24/08/2018 - 13:50

A new review article has been published, Thymidine Kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker, that analyses and summarizes recent publications describing research on TK1 [...]

Announcement no. 6/2018 - Financial calendar 2018/19

24/08/2018 - 13:31

Please see enclosed pdf. Attachment 6-18 Financial Calendar 2018-19

Biohit Oyj: Managers' Transactions

24/08/2018 - 13:30

BIOHIT OYJ MANAGERS’ TRANSACTIONS 24 AUGUST 2018 At 14.30 local time (EET) Biohit Oyj: Managers' Transactions Person subject to the notification requirement Name: Semi Korpela Position: Chief Executive Officer Issuer: [...]

Biohit Oyj: Managers' Transactions

24/08/2018 - 13:30

BIOHIT OYJ MANAGERS’ TRANSACTIONS 24 AUGUST 2018 At 14.30 local time (EET) Biohit Oyj: Managers' Transactions Person subject to the notification requirement Name: Ilari Patrakka Position: Other Senior Management Issuer [...]

Resonant Inc. to Present at the Rodman & Renshaw 20th Annual Global Investment Conference

24/08/2018 - 13:05

GOLETA, Calif., Aug. 24, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for wireless devices, is scheduled to [...]

R1 RCM to Present at the Baird 2018 Global Healthcare Conference

24/08/2018 - 13:00

CHICAGO, Aug. 24, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of revenue cycle management and physician advisory services to healthcare providers, today announced its management team will [...]

RedHill Biopharma to Host Second Quarter 2018 Financial Results Conference Call on August 30, 2018

24/08/2018 - 13:00

TEL-AVIV, Israel and RALEIGH, N.C., Aug. 24, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]

Key information relating to the preferential rights issue to be carried out by PCI Biotech Holding ASA

24/08/2018 - 08:58

Date on which the terms and conditions of the preferential rights issue were announced: 24 august 2018 Last day including right: 14 September 2018 Ex-date: 17 September 2018 Record Date: 18 September 2018 Date of [...]

PCI Biotech: Notice of Extraordinary General Meeting

24/08/2018 - 08:47

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH AFRICA, OR ANY OTHER [...]

Registration of merger, de-listing of Oncology Venture from Spotlight Stock Market, last day of trading and record date for the merger

24/08/2018 - 08:31

Hoersholm, Denmark, August 24, 2018 - Medical Prognosis Institute A/S (now Oncology Venture A/S) (the " Company ") and Oncology Venture Sweden AB (" OV ") hereby announce, as part of the completion of the previously [...]

Xbrane Biopharma releases interim report for the second quarter of 2018

24/08/2018 - 08:01

Press release 2018-08-24 Xbrane Biopharma AB's (publ.) ("Xbrane") interim report for the second quarter of 2018 is now available on the Company's website, www.xbrane.com . Financial summary second quarter 2018 Revenues [...]

Shire plc: Rule 2.9 Announcement

24/08/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 24 August 2018 [...]

Shire Announces FDA Approval of TAKHZYRO™ (lanadelumab-flyo), a First-of-its-Kind mAb Preventive Treatment for Hereditary Angioedema

24/08/2018 - 08:00

Shire Announces FDA Approval of TAKHZYRO ™ (lanadelumab-flyo), a First-of-its-Kind mAb Preventive Treatment for Hereditary Angioedema - In the pivotal study, patients taking TAKHZYRO 300 mg every 2 weeks had an 87% [...]

Navamedic ASA: Q2 2018 results

24/08/2018 - 07:58

Oslo, August 24, 2018 - Navamedic ASA (OSE: NAVA) reported revenues of NOK 45.2 million in the second quarter of 2018, down from NOK 89.7 million in the same period in 2017, following the planned discontinuation of the [...]

PCI Biotech convenes an extraordinary general meeting to propose a fully underwritten Rights Issue of NOK 360 million

24/08/2018 - 07:30

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH AFRICA, OR ANY OTHER [...]

Navamedic ASA: Q2 2018 results

24/08/2018 - 07:25

Oslo, August 24, 2018 - Navamedic ASA (OSE: NAVA) reported revenues of NOK 45.2 million in the second quarter of 2018, down from NOK 89.7 million in the same period in 2017, following the planned discontinuation of the [...]